INTERNATIONAL PATENT: KEYMED BIOSCIENCES (CHENGDU) CO., LTD. FILES APPLICATION FOR "ANTIBODIES TARGETING OX40L AND IL-13 AND USES THEREOF"

GENEVA, Dec. 21 -- KEYMED BIOSCIENCES (CHENGDU) CO., LTD. (Building D2, No. 18, Bio-Town Middle Road, Chengdu Tianfu International Bio-Town, Shuangliu DistrictChengdu, Sichuan 610219) filed a patent application (PCT/CN2025/100713) for "ANTIBODIES TARGETING OX40L AND IL-13 AND USES THEREOF" on Jun 12, 2025. With publication no. WO/2025/256597, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHEN, Bo (4th Floor, 12 C1 Incubator Building, 88 South Keyuan Road, High-Tech ZoneChengdu, Sichuan 610041), WANG, Changyu (Building D...